Innospec (IOSP) SVP David B. Jones receives 1,903-share stock award

Rhea-AI Filing Summary

INNOSPEC INC. senior vice president, general counsel and chief compliance officer David B. Jones acquired 1,903 shares of common stock on February 16, 2026 through the settlement of a performance-based restricted stock unit award originally granted on February 27, 2023. The award carried no cash purchase price per share. Following this equity grant, Jones directly holds a total of 13,603 shares of Innospec common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones David B.

(Last) (First) (Middle)

8310 SOUTH VALLEY HIGHWAY

SUITE 350

(Street)

ENGLEWOOD CO 80112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INNOSPEC INC. [ IOSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, GC & CCO

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/16/2026		A		1,903(1)	A	$0.00	13,603	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of common stock acquired upon settlement of a performance-based restricted stock unit award granted to the reporting person on February 27, 2023.

	David Bentley Jones	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Innospec (IOSP) report for David B. Jones?

Innospec reported that David B. Jones acquired 1,903 shares of common stock. The shares were received as settlement of a performance-based restricted stock unit award, not through an open-market purchase, and increased his direct holdings to 13,603 shares.

Was the Innospec (IOSP) insider stock award to David B. Jones a purchase or a grant?

The transaction was a grant, not a cash purchase. David B. Jones received 1,903 shares of common stock upon settlement of a performance-based restricted stock unit award originally granted on February 27, 2023.

What price did David B. Jones pay per share in the latest Innospec (IOSP) Form 4 filing?

David B. Jones paid no cash price for the shares, which are recorded at $0.0000 per share. The 1,903 shares were issued to him as part of a performance-based restricted stock unit award settlement.

How many Innospec (IOSP) shares does David B. Jones own after this Form 4 transaction?

After the reported transaction, David B. Jones directly owns 13,603 shares of Innospec common stock. This total reflects the addition of 1,903 shares received from a performance-based restricted stock unit award settlement.

What is the origin of the performance-based RSU settled in the Innospec (IOSP) Form 4?

The settled award originated from a performance-based restricted stock unit grant made on February 27, 2023. On February 16, 2026, 1,903 Innospec common shares were delivered to David B. Jones upon settlement of that award.